arrow
返回
M

M.K. Parmar

university of london

4H指数
11论文数
45被引数
收录论文 4
发表时间
The STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617) trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) starting androgen deprivation therapy (ADT)STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617)试验:一项在开始雄激素剥夺疗法(ADT)的转移性前列腺癌(mPC)患者中进行的III期、随机、开放标签试验
err2024-09-01
err0
PREAI
errPadden-Modi, M.; Abdel-Aty, H.; Jones, C.; Brown, L. C.; Dutey-Magni, P.; Yogeswaran, Y.; Horsey, A.; Amos, C. L.; Murray, I.; Hujairi, N.; Tunariu, N.; Millman, R.; Cross, W.; Kasivisvanathan, V.; Parmar, M. K.; Clarke, N.; Gillessen, S.; Attard, G.; Parker, C.; James, N. D.
err分享
err收藏
Assessing PSA
err2023-10-01
err0
PREAI
errHalabi, S.; Roy, A.; Guo, S.; Rydzewska, L.; Godolphin, P. J.; Parmar, M. K.; Hussain, M.; Tangen, C.; Thompson, I. M.; Carducci, M. A.; Smith, M. R.; Morris, M. J.; Gravis, G.; Dearnaley, D.; Verhagen, P.; Goto, T.; James, N. D.; Buyse, M. E.; Tierney, J.; Sweeney, C.
err分享
err收藏
Impact of Node Status and Radiotherapy on Failure-Free Survival in Patients With Newly-Diagnosed Non-Metastatic Prostate Cancer: Data From > 690 Patients in the Control Arm of the STAMPEDE Trial
err2014-09-01
err8
errOAAI
errJames, N. D.; Spears, M. R.; Clarke, N. W.; Sydes, M. R.; Parker, C. C.; Dearnaley, D. P.; Russell, J. M.; Ritchie, A. W. S.; Thalmann, G.; De Bono, J. S.; Attard, G.; Amos, C.; Parmar, M. K.; Mason, M. D.
err分享
err收藏